MMedication Read More What to know about Medicare’s $50 GLP-1 programJuly 1, 2026 NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper…
HHealth Read More Pharmacy expert calls for hybrid digital-human models in NHS healthcareJune 30, 2026 A pharmacy academic from Kingston University has provided special expertise to the UK Parliament on two key Health…
HHealth Read More Lost weight is less likely to return when exercise follows obesity treatmentJune 24, 2026 Exercise may offer a modest but measurable defense against weight regain after dieting or bariatric surgery, but the…
MMedication Read More Regulators issue warning on ads for unlicensed weight loss drugs – Chemist+DruggistJune 20, 2026 Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistOral Wegovy regulatory filing in China supports Novo Nordisk…
FFitness Read More Walking 6K, 12K or 18K steps a day? Fitness coach reveals how many pounds of fat you could loseJune 16, 2026 If you’re looking for a sustainable way to lose weight, the answer could be as simple as putting…
MMedication Read More Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even BetterJune 4, 2026 Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
MMedication Read More Foundayo and Zepbound now covered for millions of AmericansMay 29, 2026 About Foundayo™ (orforglipron)3 Foundayo™ (orforglipron) is FDA-approved for adults with obesity, or some adults with overweight who also have…
MMedication Read More For Some Women, Weight Loss Drugs Are a Secret They Keep From Their PartnersApril 21, 2026 The first time Caroline went on Wegovy, it wasn’t a secret: She told her boyfriend, mother, and close…
FFitness Read More Chennai fitness trainer explains why strength training should be a central part of your weight loss journeyApril 17, 2026 A successful weight loss journey is often built on three key pillars – diet, exercise, and sleep –…
MMedication Read More Are GLP-1 Drugs Quietly Changing Our Sex Lives?April 13, 2026 By now you’ve probably heard about GLP-1s, sold under brand names such as Ozempic and Wegovy. This class…
MMedication Read More Divorce boom may follow use of Ozempic and other GLP-1 drugs, experts warnApril 11, 2026 The exploding popularity of GLP-1 receptor agonists like Ozempic and Wegovy is often hailed as a public health…
HHealth Read More Metformin boosts an exercise-linked metabolite and may help control weight in prostate cancer patientsApril 8, 2026 A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe…